Cutaneous Lupus Erythematosus Treatment Revolution: Exploring the Latest Nano Lipid Drug Delivery Innovations

: This review article aims to explore recent advancements in the treatment of Cutaneous Lupus Erythematosus (CLE) by focusing on the innovative use of Nano Lipid Carrier formulations. It assesses the efficacy, safety, and potential therapeutic benefits of these novel formulations in managing CLE symptoms. A comprehensive search was conducted across various scientific databases, including PubMed, MEDLINE, and Google Scholar, to identify relevant studies, clinical trials, and reviews pertaining to CLE treatment, particularly those involving various NLC formulations. Studies were selected based on their relevance to CLE treatment, with a specific emphasis on recent innovations. Data extraction involved gathering information on study design, intervention methods, outcomes, and conclusions related to the efficacy and safety of novel formulations in managing CLE symptoms. The synthesized data reveal promising outcomes associated with the use of NLC in treating CLE. These formulations offer enhanced drug delivery, improved skin penetration, and targeted therapy, resulting in better symptom management and reduced adverse effects compared to conventional treatments. Various studies demonstrate the efficacy of NLC embedded in reducing inflammation, controlling disease activity, and improving the quality of life for CLE patients. The latest advancements in CLE treatment, using novel methods, present a significant revolution in managing this chronic autoimmune skin condition. The reviewed literature highlights the potential of Nano lipid carrier embedded hydrogel as a promising therapeutic approach for CLE, offering improved efficacy, safety, and patient compliance. Further research and clinical trials are warranted to validate these findings and establish NLC as a standard treatment modality for CLE.